https://www.openbell.ai/ 2026-10-16T15:10:09.625Z hourly 1.0 https://www.openbell.ai/support 2026-10-16T15:10:09.625Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-16T15:10:09.625Z monthly 0.5 https://www.openbell.ai/terms 2026-10-16T15:10:09.625Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-16T15:10:09.625Z hourly 0.8 https://www.openbell.ai/news/RKLB:1792163257072 2026-10-16T15:07:37.072Z daily 0.9 https://cdn.brandfetch.io/RKLB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rocket Lab shares are trading lower after Citizens lowered its price target on the stock from $130 to $90. openbell Financial News https://www.openbell.ai/news/EWTX:1792163152572 2026-10-16T15:05:52.572Z daily 0.9 https://cdn.brandfetch.io/EWTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Edgewise Therapeutics with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Edgewise Therapeutics (NASDAQ: EWTX) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/HUT:1792163094722 2026-10-16T15:04:54.722Z daily 0.9 https://cdn.brandfetch.io/HUT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hut 8 shares are trading lower after Cantor Fitzgerald lowered its price target on the stock from $180 to $151. openbell Financial News https://www.openbell.ai/news/LLY:1792163071799 2026-10-16T15:04:31.799Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Los-Angeles--California---July-7-2025-El.jpg?width=250&height=187 Eli Lilly's GLP-1 Pill Wins Key European Backing for Obesity and Diabetes Eli Lilly and Co's new medication, Foundayo, has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for marketing authorization in Europe, aimed at treating type 2 diabetes and aiding weight management. Foundayo, which contains the active ingredient orforglipron, is indicated for adults with obesity or overweight conditions alongside diet and exercise. Following the announcement, Eli Lilly's stock rose by 1.44% to $1269.60, nearing its 52-week high of $1292.65. https://www.openbell.ai/news/JKHY:1792163013340 2026-10-16T15:03:33.340Z daily 0.9 https://cdn.brandfetch.io/JKHY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Jack Henry To Provide Tokenized Deposits Under Expanded Partnership With Google Cloud Through Universal Ledger Jack Henry (NASDAQ: JKHY) has announced an expansion of its partnership with Google Cloud to provide tokenized deposits through the Google Cloud Universal Ledger (GCUL). This collaboration positions Jack Henry as the first core technology provider to integrate with GCUL, enabling banks and credit unions to modernize their deposit offerings and enhance customer relationships. GCUL is a managed distributed ledger service that allows financial institutions to tokenize and transfer assets with real-time settlement capabilities. https://www.openbell.ai/news/RVMD:1792162969433 2026-10-16T15:02:49.433Z daily 0.9 https://cdn.brandfetch.io/RVMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Revolution Medicines with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Revolution Medicines (NASDAQ: RVMD) with an Outperform rating. This marks a positive outlook for the company as it enters a new phase of market analysis. https://www.openbell.ai/news/PSX:1792162945267 2026-10-16T15:02:25.267Z daily 0.9 https://cdn.brandfetch.io/PSX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Phillips 66 Raises Quarterly Dividend From $1.27 To $1.33 Per Share Phillips 66 (NYSE: PSX) has announced an increase in its quarterly dividend from $1.27 to $1.33 per share, marking a $0.06 increase. The new dividend will be payable on December 1, 2026, to shareholders on record as of November 17, 2026. https://www.openbell.ai/news/SPY:1792162820453 2026-10-16T15:00:20.453Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Charts-Of-Financial-Instruments-With-Var.jpg?width=250&height=187 9 Of 11 Sectors Rise In Friday Trading As Cyclicals Lead On Friday, nine of the eleven sectors in the market experienced gains, with the Materials sector leading at +1.62%, followed by Energy at +1.14% and Financials at +0.99%. The major averages showed mixed results, with the SPDR S&P 500 ETF Trust (SPY) down 0.06% and the Invesco QQQ Trust down 0.92%, while the Dow Jones Industrial Average ETF rose 0.42%. Notably, the Technology sector lagged, declining by 1.28%, driven by losses in major companies like Oracle and Microsoft. https://www.openbell.ai/news/UCBJF:1792162421609 2026-10-16T14:53:41.609Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Doctor-Working-On-Virtual-Touch-Screen-P.jpg?width=250&height=187 UCB Scores FDA Win With First-Of-Its-Kind Daily Autoinjector for Rare Muscle Disorder UCB SA has received FDA approval for its Zilbrysq autoinjector, the first self-administered, once-daily treatment for generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor antibody-positive. The approval is based on data from three studies, including a Phase 3b study showing a 99.8% complete dose delivery rate. The autoinjector is expected to be commercially available in the first quarter of 2027, complementing UCB's existing gMG portfolio, which includes RYSTIGGO. https://www.openbell.ai/news/CLW:1792162251061 2026-10-16T14:50:51.061Z daily 0.9 https://cdn.brandfetch.io/CLW/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Clearwater Paper, Raises Price Target to $23 RBC Capital analyst Matthew McKellar has maintained an Outperform rating on Clearwater Paper (NYSE: CLW) and raised the price target from $21 to $23. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/CYTK:1792162194933 2026-10-16T14:49:54.933Z daily 0.9 https://cdn.brandfetch.io/CYTK/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Cytokinetics with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Cytokinetics (NASDAQ: CYTK) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/NVA:1792162092554 2026-10-16T14:48:12.554Z daily 0.9 https://cdn.brandfetch.io/NVA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Spruce Point Capital Raises Concern Over Nova Minerals' Purchase Of Antimony Ore In FY26; Says Its Running Out Of Cash Spruce Point Capital has raised concerns regarding Nova Minerals' acquisition of antimony ore scheduled for fiscal year 2026, highlighting potential financial instability as the company is reportedly running out of cash. The situation may impact Nova Minerals' operational capabilities and future growth prospects. Investors should monitor these developments closely, as they could affect the stock performance of NVA. https://www.openbell.ai/news/KARD:1792162070752 2026-10-16T14:47:50.752Z daily 0.9 https://cdn.brandfetch.io/KARD/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Kardigan with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Kardigan (NASDAQ: KARD) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/KRMN:1792162066229 2026-10-16T14:47:46.229Z daily 0.9 https://cdn.brandfetch.io/KRMN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Karman Holdings shares are trading higher after Macquarie initiated coverage on the stock with an Outperform rating and announced a $65 price target. openbell Financial News https://www.openbell.ai/news/CAS:1792162059501 2026-10-16T14:47:39.501Z daily 0.9 https://cdn.brandfetch.io/CAS/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Cascades, Raises Price Target to C$21 RBC Capital analyst Matthew McKellar has maintained an Outperform rating on Cascades (TSX: CAS) and increased the price target from C$18 to C$21. This adjustment reflects a positive outlook for the company. https://www.openbell.ai/news/ETHA:1792162010566 2026-10-16T14:46:50.566Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Eth-Coin-With-Blurred-Candlestick-Chart-.jpg?width=250&height=187 Ethereum ETFs See $60 Million Outflows: Why BlackRock’s ETHA Is Facing Selling Pressure U.S. spot Ethereum ETFs experienced $60.22 million in net outflows on Thursday, marking the second consecutive day of withdrawals, with BlackRock's iShares Ethereum Trust ETF (ETHA) leading the decline at $44.39 million. In contrast, Fidelity's Ethereum Fund (FETH) attracted $2.44 million in inflows, highlighting divergent investor behavior. Despite the outflows, total net assets for U.S. spot Ethereum ETFs remain at $15.29 billion, approximately 5.10% of Ethereum's market capitalization. Investors are closely monitoring Ethereum's upcoming fourth-quarter network upgrade as a potential catalyst for renewed interest in the cryptocurrency. https://www.openbell.ai/news/IMNM:1792161980294 2026-10-16T14:46:20.294Z daily 0.9 https://cdn.brandfetch.io/IMNM/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Immunome with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Immunome (NASDAQ: IMNM) with an Outperform rating. This marks a significant endorsement for the company as it seeks to attract investor interest. https://www.openbell.ai/news/CRCL:1792161899813 2026-10-16T14:44:59.813Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/The-Circle-Trade.jpg?width=250&height=187 Circle Eyes 40 New Markets as Stablecoin Demand Booms, AI Payments Gain Traction Circle Internet Group, Inc. (NYSE: CRCL) plans to expand into nearly 40 emerging markets due to rising demand for stablecoins, as stated by CEO Jeremy Allaire. The company's USDC circulation increased by 19% year-over-year to $73.3 billion in Q2 2026, and it holds nearly 25% of the stablecoin market. Circle recently acquired Tazapay for $400 million and secured a $100 million investment from Binance to enhance its global presence. Analysts expect Circle to report earnings of 36 cents per share on November 4, with projected revenue of $780.98 million. https://www.openbell.ai/news/TNGX:1792161874800 2026-10-16T14:44:34.800Z daily 0.9 https://cdn.brandfetch.io/TNGX/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Tango Therapeutics with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Tango Therapeutics (NASDAQ: TNGX) with an Outperform rating. This marks a significant endorsement for the company in the market. https://www.openbell.ai/news/CRWV:1792161842401 2026-10-16T14:44:02.401Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Los-Angeles--California---July-7-2025-Co.jpg?width=250&height=187 CoreWeave Has ‘Darwin Moment’ As Credit Markets Price In 60% Default Odds CoreWeave Inc. (NASDAQ: CRWV) is facing significant financial challenges as its shares fell 6.4% to $65.25, marking a potential weekly loss of about 22%. The company's five-year credit default swaps reached a record 1,194.5 basis points, indicating over a 60% chance of default within five years. CoreWeave generated $679 million in operating cash flow in Q2 but spent approximately $6.4 billion on equipment, leading to a net interest expense that more than doubled to $640 million. https://www.openbell.ai/news/IDYA:1792161741953 2026-10-16T14:42:21.953Z daily 0.9 https://cdn.brandfetch.io/IDYA/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On IDEAYA Biosciences with Outperform Rating William Blair analyst Alethia Young has initiated coverage on IDEAYA Biosciences (NASDAQ: IDYA) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/NI:1792161741492 2026-10-16T14:42:21.492Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Kiev--Ukraine---Jan-7--2019-Nisource-Uti.jpg?width=250&height=187 NiSource Lands Major Microsoft Power Deal NiSource Inc. has entered into a 20-year power supply agreement with Microsoft Corp. to support a data center in northwest Indiana, which will add approximately 1,100 megawatts of new power generation capacity. This deal is expected to increase savings for Northern Indiana Public Service Company (NIPSCO) customers from $1.4 billion to $1.75 billion, translating to an estimated $140 annual savings per customer. NiSource plans to provide further financial details during its upcoming earnings call on October 28, where analysts expect earnings per share of 21 cents and revenue of $1.33 billion. https://www.openbell.ai/news/AA:1792161728618 2026-10-16T14:42:08.618Z daily 0.9 https://cdn.brandfetch.io/AA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of aluminum-related companies are trading higher after Alcoa's better-than-expected Q3 adjusted EPS results and comments that inventories leave little room for another market shock. Also, reports suggesting that U.S. Commerce Secretary Lutnick is refusing to give concessions to Mexican aluminum imports may also aid sentiment for the sector. openbell Financial News https://www.openbell.ai/news/SHOP:1792161702326 2026-10-16T14:41:42.326Z daily 0.9 https://cdn.brandfetch.io/SHOP/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Shopify, Raises Price Target to C$200 RBC Capital analyst Paul Treiber has maintained an Outperform rating on Shopify (TSX: SHOP) and increased the price target from C$180 to C$200. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/PVLA:1792161652409 2026-10-16T14:40:52.409Z daily 0.9 https://cdn.brandfetch.io/PVLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Palvella Therapeutics with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Palvella Therapeutics (NASDAQ: PVLA) with an Outperform rating. This marks a significant endorsement for the company as it seeks to enhance its market presence. https://www.openbell.ai/news/SHOP:1792161627985 2026-10-16T14:40:27.985Z daily 0.9 https://cdn.brandfetch.io/SHOP/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Shopify, Raises Price Target to $200 RBC Capital analyst Paul Treiber has maintained an 'Outperform' rating on Shopify (NASDAQ: SHOP) and increased the price target from $180 to $200. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/WVE:1792161540570 2026-10-16T14:39:00.570Z daily 0.9 https://cdn.brandfetch.io/WVE/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Wave Life Sciences with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Wave Life Sciences (NASDAQ: WVE) with an Outperform rating. This marks a positive outlook for the company as it enters a new phase of market evaluation. https://www.openbell.ai/news/EIDO:1792161486574 2026-10-16T14:38:06.574Z daily 0.9 https://cdn.brandfetch.io/EIDO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of U.S.-listed Indonesian companies are trading lower after the MSCI announced the launch of a consultation on a proposal to reclassify the MSCI Indonesia Indexes from Emerging Market to Standalone Market status. openbell Financial News https://www.openbell.ai/news/NUE:1792161450176 2026-10-16T14:37:30.176Z daily 0.9 https://cdn.brandfetch.io/NUE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Shares of steelmakers are trading higher as U.S. steel prices reach a four-year high due to import tariffs. Also, reports suggesting that U.S. Commerce Secretary Lutnick is refusing to give concessions to Mexican steel imports may also be bolstering expectations that protectionism will aid pricing power and margin expansion. openbell Financial News https://www.openbell.ai/news/RYTM:1792161393620 2026-10-16T14:36:33.620Z daily 0.9 https://cdn.brandfetch.io/RYTM/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Rhythm Pharmaceuticals with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Rhythm Pharmaceuticals (NASDAQ: RYTM) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/TCXB:1792161300480 2026-10-16T14:35:00.480Z daily 0.9 https://cdn.brandfetch.io/TCXB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO security released for quotation openbell Financial News https://www.openbell.ai/news/FTH:1792161103224 2026-10-16T14:31:43.224Z daily 0.9 https://cdn.brandfetch.io/FTH/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Faeth Therapeutics with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Faeth Therapeutics (NASDAQ: FTH) with an Outperform rating. This marks a significant endorsement for the company in the financial markets. https://www.openbell.ai/news/STX:1792161048309 2026-10-16T14:30:48.309Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Seagate-Technology-Logo-And-Sign.jpg?width=250&height=187 Seagate, Western Digital Face Supply Risks as AI Demand Drives Capacity Expansion Seagate Technology Holdings Plc. (NASDAQ: STX) and Western Digital Corp. (NASDAQ: WDC) are experiencing stock declines due to investor concerns over supply growth and financing risks related to AI infrastructure expansion. Both companies have seen their stocks drop approximately 5% recently, despite being up 110% to 150% in 2026. Increased competition, particularly from Toshiba's plans to double HDD manufacturing capacity by 2027, has raised pricing concerns, while Wall Street firms like UBS have lowered price forecasts amid scrutiny of supply-demand conditions. https://www.openbell.ai/news/NBIS:1792161043080 2026-10-16T14:30:43.080Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Nebius-Group.jpg?width=250&height=187 Why Is Nebius Group Stock Falling Friday? Nebius Group N.V. (NASDAQ: NBIS) stock fell nearly 6% on Friday, trading at $177.29, amid concerns over artificial intelligence infrastructure spending following a Gartner warning that over 80% of neocloud providers may cease independent operations by 2030. The broader technology sector is also experiencing selling pressure, with the Nasdaq down 0.83%. Nebius is expected to report a quarterly loss of 79 cents per share, with revenue projected to rise to $904.29 million from $146.10 million, while analysts maintain a Buy consensus rating with an average price target of $272.62. https://www.openbell.ai/news/RCUS:1792161003574 2026-10-16T14:30:03.574Z daily 0.9 https://cdn.brandfetch.io/RCUS/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Initiates Coverage On Arcus Biosciences with Outperform Rating William Blair analyst Alethia Young has initiated coverage on Arcus Biosciences (NYSE: RCUS) with an Outperform rating. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/TSLA:1792160631912 2026-10-16T14:23:51.912Z daily 0.9 https://cdn.brandfetch.io/TSLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Slovakia Approves Tesla Full Self-Driving System Slovakia has approved Tesla's Full Self-Driving system, marking a significant regulatory milestone for the company. This approval may enhance Tesla's competitive edge in the autonomous vehicle market. The stock ticker for Tesla is TSLA. https://www.openbell.ai/news/MBLY:1792160442758 2026-10-16T14:20:42.758Z daily 0.9 https://cdn.brandfetch.io/MBLY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Initiates Coverage On Mobileye Global with Buy Rating, Announces Price Target of $11 Citigroup analyst Michael Ward has initiated coverage on Mobileye Global (NASDAQ: MBLY) with a Buy rating. The firm has set a price target of $11 for the stock. https://www.openbell.ai/news/INDB:1792160379430 2026-10-16T14:19:39.430Z daily 0.9 https://cdn.brandfetch.io/INDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Independent Bank Corp. shares are trading higher after the company reported better-than-expected Q3 financial results. openbell Financial News https://www.openbell.ai/news/NTRP:1792160360107 2026-10-16T14:19:20.107Z daily 0.9 https://cdn.brandfetch.io/NTRP/w/400/h/400?c=1idopYfmtR7ZKg8QMud NextTrip shares are trading lower after the company reported worse-than-expected Q2 financial results. openbell Financial News https://www.openbell.ai/news/OMER:1792160282793 2026-10-16T14:18:02.793Z daily 0.9 https://cdn.brandfetch.io/OMER/w/400/h/400?c=1idopYfmtR7ZKg8QMud Omeros shares are trading lower after the company announced that the EMA’s CHMP issued a negative opinion on its marketing authorization application for narsoplimab in TA-TMA, following re-examination of its original negative opinion adopted in June 2026. openbell Financial News https://www.openbell.ai/news/HAIN:1792160214742 2026-10-16T14:16:54.742Z daily 0.9 https://cdn.brandfetch.io/HAIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hain Celestial Group shares are trading lower following a report suggesting that the company is weighing a possible Chapter 11 bankruptcy filing. openbell Financial News https://www.openbell.ai/news/VRNS:1792160207603 2026-10-16T14:16:47.603Z daily 0.9 https://cdn.brandfetch.io/VRNS/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Downgrades Varonis Systems to Hold, Lowers Price Target to $49.75 TD Cowen analyst Shaul Eyal has downgraded Varonis Systems (NASDAQ: VRNS) from a Buy rating to Hold. The price target for the stock has also been reduced from $56 to $49.75. https://www.openbell.ai/news/CACI:1792160187430 2026-10-16T14:16:27.430Z daily 0.9 https://cdn.brandfetch.io/CACI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Macquarie Initiates Coverage On CACI International with Outperform Rating, Announces Price Target of $780 Macquarie analyst Marni Lysaght has initiated coverage on CACI International (NYSE: CACI) with an Outperform rating. The firm has set a price target of $780 for the company's stock. https://www.openbell.ai/news/SMTC:1792160088973 2026-10-16T14:14:48.973Z daily 0.9 https://cdn.brandfetch.io/SMTC/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Reiterates Buy on Semtech, Maintains $215 Price Target TD Cowen analyst Sean O'Loughlin has reiterated a Buy rating on Semtech (NASDAQ: SMTC) and maintained a price target of $215 for the stock. This endorsement suggests confidence in the company's future performance and potential for growth. https://www.openbell.ai/news/ACN:1792159996036 2026-10-16T14:13:16.036Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Warsaw--Poland---May-2020-Accenture-Comp.jpg?width=250&height=187 Accenture Analysts Raise Price Targets as AI Fuels Multi-Year Growth Plan Analysts have raised their price targets for Accenture plc (NYSE: ACN) following the company's multi-year growth plan presented at its Investor Day. TD Cowen's Bryan C. Bergin increased his target from $193 to $201, while Susquehanna's James Friedman raised his from $210 to $230. Accenture aims for mid-single-digit revenue growth through fiscal 2027 and 2028, accelerating to mid- to high-single-digit growth in fiscal 2029, with a target of at least $9.5 billion in free cash flow for fiscal 2029. https://www.openbell.ai/news/RHHBY:1792159988779 2026-10-16T14:13:08.779Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Eye-In-Close-Up-With-Light-Blue-Iris-Det.jpg?width=250&height=187 Roche Secures FDA Approval for First At-Home Thyroid Eye Disease Therapy Roche Holdings AG received FDA approval for Enspryng (satralizumab), the first at-home therapy for thyroid eye disease. The approval was based on the Phase 3 SatraGO trials, where Enspryng showed a 52.9% proptosis response rate compared to 23.4% for placebo, and a 60.7% reduction in double vision versus 25.8% in the control group. Following the announcement, Roche's stock price increased by 0.93% to $57.31. https://www.openbell.ai/news/SITC:1792159979012 2026-10-16T14:12:59.012Z daily 0.9 https://cdn.brandfetch.io/SITC/w/400/h/400?c=1idopYfmtR7ZKg8QMud SITE Centers shares are trading higher after the company announced a $3 per share special cash distribution and a plan to voluntarily delist from the New York Stock Exchange. openbell Financial News https://www.openbell.ai/news/LUNR:1792159970638 2026-10-16T14:12:50.638Z daily 0.9 https://cdn.brandfetch.io/LUNR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Macquarie Initiates Coverage On Intuitive Machines with Outperform Rating, Announces Price Target of $25 Macquarie analyst Marni Lysaght has initiated coverage on Intuitive Machines (NASDAQ: LUNR) with an Outperform rating. The firm has set a price target of $25 for the company's stock. https://www.openbell.ai/news/FTAI:1792159812178 2026-10-16T14:10:12.178Z daily 0.9 https://cdn.brandfetch.io/FTAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Macquarie Initiates Coverage On FTAI Aviation with Outperform Rating, Announces Price Target of $305 Macquarie analyst Marni Lysaght has initiated coverage on FTAI Aviation (NASDAQ: FTAI) with an Outperform rating. The firm has set a price target of $305 for the company's stock. https://www.openbell.ai/news/LADR:1792159743475 2026-10-16T14:09:03.475Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/16/Display-Of-Stock-Market-Quotes.jpg?width=250&height=187 Ladder Capital Posts Upbeat Q3 Earnings, Joins Alcoa, Hyster-Yale And Other Big Stocks Moving Higher On Friday Ladder Capital Corp (NYSE: LADR) reported third-quarter earnings of 35 cents per share, surpassing the analyst consensus estimate of 31 cents, and quarterly sales of $118.904 million, exceeding expectations of $79.433 million. Following the announcement, Ladder Capital shares rose 3.3% to $9.11. The overall U.S. stock market showed mixed results, with the Dow Jones gaining approximately 250 points on the same day.